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The vascuhw endathelium importantly modulates mvly biwbm. 
ical and physiologic properties of Ihe vaseul~r wall, including the 
releaw of p+eot vawactiw factors, maintenattce of ao antlcoug. 
ulsnt state sod modulation of vaxular growth by the t~leaw of 
both prdiferative and aotiproliferstive substances. Rominont 
among these rodothelist rote is the prmhwdan of a potent 
vasodilntor or family of va9oditatorJ termed the eodothrtium. 
derived relaxing B&r, one of which has been identified to be 
nitric oxide ur a closely related coiupound. Several diwases that 
Historically, the vascular endothelium was thought to serve 
its primor; purpose as a barrier to the diffusion of macro- 
molecules. It was not until the 1980s that i( became apparent 
that this cell layer is metabolically very active and plays a 
major role in modulating vast-lar smaolh muscle tone. In 
1980, Furchkwtt and Zawadski (I) made the impmtant oh- 
serwion that the endothelium had to be present for acetyt- 
choline to produce vascular relaxation. 11 is now known that 
the endothelium releases a variety of potent wsoaclive 
substances. These include prosracyclin (2.3). the endotheli- 
urn-derived relaxing factor (responsible for the effect of 
acetylcholine and a variety of alher neurohumoral sub- 
stances) ll,4,5). angiotensin II (6). several vasoconstrictor 
prostaglandins (7.8). the superoxide anion (which may serve 
as a vasoconstrictor) (9) and endothelin (IW. 
The Endothelium-Derived Relaxing Factor 
By far the mo51 carefully rtudied of there compounds in 
the seuing of disease is the endothelium-derived relaxing 
factor. This subswwe has now been identified to be either 
nitric oxide (II) or L related nitrorylaled compound t I?) and 
produces vascular relaxation by activatmg uanylate cyclase 
within the adjacent vascular smoulh muscle ll3-IS). Re- 
cently, an enzyme responsible for producrion of n~tnc oxide 
cmmonly emu in patIm uodrrgoing mmm-y anpjcpasty 
alter many facets of enddhelial fu~~~tion and may prediipw to 
adverse clinical scqwlae of sngiopt&ty, iocludii inuwdiite 
thmmbmis, rerttnoriraod rarularsp~~rn. Severalfeatumoftbe 
eodotheliumderived retexing factor, ho- it b altered by path+ 
loate pmwszus sod how dwx ce&de&~ r&Se to the hum* 
diate and late pm(sngioplasty periods are dtwnwt. 
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by oxidatmn of the ~uanidino-nitrogen of arginine has been 
ldcntificd f 16.17). This cyrosolic enzyme IS activated by an 
intenct~oo of calcium and calmodulin and requires uicolin- 
amide &nine dinucleotide phosphate, reduced form 
INADPHI as a cofactor. Recenr work has shown that 
nitrogen oxides produced by other mammalian cells, includ- 
ing macrophages <18.19). lung (20). brain (171. liver (?I) and 
astroglial cells (22). may have important biologic activities. 
There remains substantial debate about whether endotbe- 
hum-derived relaxing factor is truly nitric oxide or perhaps a 
related nitrosylatcd compound. This is bt..ase the method 
usuallv emoloved to detect nitric oxide cannot differentiate 
between n&c oxide and other compounds that may yield 
nitric oxide either spontaneously or after a I elfetron reduc- 
tion. The precise chemical nuture of end.olhelium-derived 
relaxing factor may have important implications regarding 
alterations of its synthesis in disease stales. 
Alternate Roles of Endothelium-Derived 
Relaxing Factor 
Inhibition d @at&t @w?gation. In addition to the po- 
tent vasorelaxard properties ofendothelium-derived relaxing 
factor. there are two other Rolex of the compound that are 
probably important. The compound acts in a synergistic 
fashion with prontacyclin to inhibit platelet aggregation 
(21-251. This pmpeny of the endothelium-derived relaxing 
factor \~a( demonstrated by several groups and is mediated 
by activation of platelet guanylate cyclase. This effect of 
endothelium-derived relaxing factor in attetwding platelet 
aggregation can most c~%Iy he demonstrated after iohibi- 
Lioo of cycl~xygenase (24,25). Recently. Mendelsohn et al. 
(26) showed that S-nitmso-N-acerylcyst~ne (a compuund 
Figure 1. Relaxarion of iliac arteries from narmal and cholesterol- 
fed monkeys wnh atherosclerosis in response to acetykholine Wt). 
thmmbin Imtddlej and the calcium ionophore A23187 (right). Yes- 
sels were studied as rings in organ chambers. After precanrtriction 
with prortaelandin F,.. either acetylcholine. thrumbin or the cak 
cium ionophore uas iiaded in increasing concenrradons. Relaxation 
in response lo thcac cndothelium-dependent vasodilarars war mark- 
edly impaired in arhemsclemtic vessels. Reprinted from Freiman et 
al. (321 and Harrison et al. 142) with permission of the American 
Heart Assoc~atmn. Inc. 
that has some similarities with endothelium.derived relax- 
ation factor) can inhibit fibrinogen binding to platelets by a 
cyclic guanadine monophosphate (GMP).mediated mecha- 
nism. 
tneetivetten c&the super&de anion. A second interesting 
role of endothelium-derived relaxing factor that may be 
important in the setting of disease states is its ability to 
inactivate the superoxide anion. This was firs1 suggested to 
be important by Feigl (27) and was recently demonstrated 
(281 to occur in an In vitro system of superoxide anion 
release from neutrophils stimulated by the tripeptide f-met- 
leu-phe. The vascular wall contains other oxidant defense 
systems, including glutathione. superoxide dismutase and 
cat&se. The relalive importance of nitric oxide in serving as 
an antioxidant remains to be defined. 11 is. however, possible 
that decreases in the production or release of endothelium- 
derived nitrogen oxides predispose to vascular oxidant in- 
jury. 
Role in restenosia. These “alternate” roles for endotheli- 
urn-derived relaxing factor are quite likely altered in the 
setting of angioplasty. either by the presence of atheroscle- 
rosis or by endothelial denudation. Of particular significance 
is the loss of the antiplatelet effect. Platelet deoosition 
undoubtedly serves as ahidus for acute thrombus i&mation 
and over the long-term is accompanied by the release of 
potent vascular growth factors that may lead to restenosis. 
Alterations of Endothelium-Dependent 
Vasodilation in Disease 
Several diseases are associated with abnormal endothelial 
regulation of vascular smooth muscle tone. Atherosclerosis 
was the first disease recognized to impair endothelium- 
dependent vascular relaxation @ii. I) (29-32). Others in- 
clude hypenension (bath acute and chronic) (8,33), diabetes 
(34) and ischemia followed by repetfttsion (3s). In many 
cases, these defects are related to decreased synthesis and 
release oCendothelium.derived relaxing factor by the vuscu- 
lar endothelium. In at least one instance (the spontweausly 
hypertensive rat) (8). the endothelium produces abnormal 
amounts of vasoconstriclor proslaglandins thal override the 
vasodilator influence cdendothelium~derived relaxing factor. 
There are many reported studies illustrating abnormali- 
ties of endolhelium-dependent vascular relaxation not only 
in eapcrimemal animals with atherosclerosis, but also in 
patients with atherosclerosis. Two groups (36.37) demon- 
strated this in vessels removed from recipients of a heat? 
transplant (36,37). Also, the response of large coronary 
arteries to intracoronary acetylcholine is converted from 
vasodilation to vasoconstriction in patients with even mini- 
mal coronary atherosclerosis (38). 
Abuermet vauronrtrietioo aCtrr eoronsey sngioplasty. 
These alterations of endothelial function mav be oarticularlv 
important in the setting of coronary anniopl&.‘During the 
immediate postangioplasty period, deposition of thrombin 
and platelets at the site of the lesion invariably follows. 
Thrombin and several platelet products (adenosine diphos- 
phate [ADPI. serotonin) normuily produce cndothelium 
Figure 2. Rerponse cd comnsry nl- 
crovesselsfrom normal monkeys and 
monkeys fed a high cholesterol diet 
for >18 monrha. “esels were st”d- 
ied in vitro in P prerrunzed state. 
Responses to either bradykinin. 
acrtykboline. A*3187 0; nitropnx- 
side were examined after precan- 
striction with the lhromboxanc 
anaIogU46619. Chronic hypercholes- 
terolem~ markediy impaxed endo- 
thelium-dependem ~.~wlar relar- 
ation but did not alter relaxation 
in response to endothedum-inde- 
pendent agonists. Reprinred from 
Sellkeet al. (39)with permission of the 
Amelican HeaR Arswiation. Inc. 
dependent vasodilation. Thrombin, ADP and serotonin. 
however, directly constrict vessels with abnormal or de- 
nuded endothelium. The patient with atherosclerosis is thus 
predisposed to abnormal vasoconstriction ar the site of 
angioplasty. even ifthe endothelium remains intact or is only 
partially denuded. Obviously. if angioplasty results in com- 
plete endothelial denudation, the predisposirion to vascular 
constriction caused by these agenlr would be great. 
Effect of Coronary Atherosclerosis on 
Coronary Microvascular Endothelium- 
Dependent Relaxation 
Impaired ondothelial rell function in the coronary micro- 
circulation. Early studies examining the effect of cholesterol 
feeding and atherosclerosis on endothelium-depcndcnt WI- 
cular relaxation invol,)ed large conduit vessels such as rabbit 
aorta. iliac arteries or epicardial coronary arterie\. It WI% 
reasonable to suspect that this defect in endothebal cell 
function might not occur in the mlcrocirculation. where 
overt atherasclerosir doa not develop. Recently. howew. 
we identified three condiltons that occur in the setting of 
coronary atherosclerosis and clearly impair endothelial cell 
function in the coronary micracirculatlon. Theze included 
chronic bypercholcsterolemia (Fig. 2) (39). ischemia fol- 
lowed by reperfusion (Fig. 31 (40) and chronic perfuwon 
through mature coronary collateral vessels 141 I. Thu,. \ev- 
end conditions that occu: a, a rewh of or coexist rcith 
coronary atherosclerosis can impair enduthelial function of 
the coronary microci~culation. II i) now clsar that coronary 
ntberosclerocir IS not simply a discase of large ve~elb. but 
alw Sect> the microvasculatorc and thus potentially WV 
alter neuronumoml regulation of tissu: perfosion. 
Microvascukdure constriction after angioplasty. Alter- 
ations of the micmvascular endothelium produced by one of 
these three mechanisms may alter perfusion in segments of 
myocardium downstream from the site of angioplasty. This 
may be particularly true in the retring of intimsl dissection. 
where thrombus formation and platelet deposition invariably 
occur. \‘asoactive products released from plctelrt and 
thrombin may thus not only produce spasm at the site of the 
angioplasty. but predispose to inappropriate microvascular 
constriction. Such phenomena may unduly the not infre- 
quent occurrence of unexplained chat pain in the hours 
vRer angioplasty. even when the site of the angioplasty is 
uidely raten,. 
Mechanisms Underlying Abnormal 
Endothelium-Dependent Vascular Relaxation 
in Atherosclerosis 
Defeel in recxptw signaling. The precise defect respowi- 
ble for abnarmaiendotheliumdependent relaxation in athcr- 
oxlemsis and other disease states remains unrdenutied. It 
her been suggested (361 that it is related to alterations of 
membrane-*ignaling mechanisms caused by chronic hyper- 
cholestemlemia. The hypothesis is based on the finding in 
5omc experiments 1361 that vessels from cholesterol-fed 
animals or arherosclerotic human vessels respond normally 
to the calcium ionophore A23187 hut demonstrate impaired 
relaution 10 an agoonist that requires mleraction with mem- 
brane receptws. This is not a uniform finding. At least two 
Figure 3. Response ol large coronary arteries CteR) and coronary 
microvessels (ri%t)lotbeendotbelium-dcpcndeP~”d~”, vasudilaroraden- 
osine dipbarphate (ADPI. Responser were obtained in normal 
vessels and in vessels after either ischemia lone II hl or iscbemia 
tt bl and reperfusion (I b). Neilher iscbemia nor iscbemia with 
repeliusion altered relaxation in respanre to ADP in the larger 
wselr. In contrast. endotbelium.dependent vascular elaxation in 
response to ADP was dramatically sltered by ischemia with reper- 
lusion in camnary micravessels. *P< 0.05. ischcmis + reperfurion 
versus contml: tp c 0.05, iscbemia V-XEUS iscbcmia + reperfusion. 
Reprinted from Quillen et al. 140) whh Pamission of the American 
Heart Association. Inc. 
studies (37.42) have shown endothelium-dewndent relax- 
ation in response to the calcium ionophore tobe abnormal in 
atherosclerosis (Fig. I) and bioassay studier (43) have dem- 
onstrated impaired release of endolhelium-derived relaxing 
factor in response to the calcium ionophore in aiheroscle- 
rotic vesse!s. 
Defect in nitric oxide synlhetase nzyme or d&dewy in 
arginine. A second mechanism potentially responsible. for 
abnormal cndothelium-dependent relaxation is related to a 
defect in the nilric oxide synthetase nzyme. a deficiency of 
one of the required cofactors or a deficiency of arginine. In 
concert with this hypothesis, recent studies (44) have sug- 
gested that high concentrations of argininc can restore 
vasodilation to normal after acetylcholine in the hindlimb of 
atherosclerotic rabbits. 
Aeeelerated egradation of endothelium-derived relaxing 
factor. Another explanation for abnormal endothelium- 
dependent relaxation in alherosclemtic vessels relales to 
accelerated degradation of endothelicm.derived relaxingfac- 
tar Several cell types within atherosclerotic blood vessels 
are capable of releasing oxygen-derived free radicals. The 
superoxide radical, io F9rhh.r. degrades endothelium- 
derived relaxing factor. presumably by reacting with nitric 
oxide to form nitrite (or reacting with a nitmsyl compound to 
heterolytically release nitrous oxide, which then is degraded 
to nitrite). This possibility is strengthened by the recent 
observation (45) that nitric oxide production by atheroscle- 
rotic vessels is actually increased rather than decreased. 
This finding strongly suggests that increased degradation 
rather than decreased synthesis of endothelium-derived re- 
laxing factor occurs in atherosclerotic vessels. Iiwthemwre, 
preliminary studies from our laboratory have shown that 
short-term (I week) treatment with polyethylene glycolated 
superoxide dismutase partially restores endothelium-de- 
cadent relaxation lo normal in cholesterol-fed rabbits. 
&nilar treatment had no effect on endothelium-dependent 
relaxation in vessels removed from normal animals. These 
studies stmngly suggest hat excess generation of the super- 
oxide anion within the atherosclerotic vessel may at least 
partly account for impaired endothelium-dependent vascular 
relations. 
Prevention or Correction of Altered 
Endothelium-Dependent Relaxation in 
Atherosclerotic Vessels 
Several investigators have attempted to prevent or COT- 
rat abnormal endothelium-dependent responses in enperi- 
mental animals. Successful approaches include the concom- 
itant administration of a calcium channel antwonist (461. 
treatment with dietary cod liver oil (47). the administration 
of PEG-SOD (oreliminarv studies from our laboratoM and 
reversion froma high ch&sterol diet to a normal diei for a 
prolonged period (Fig. 4) (48). Recently, Vckshtein et al. (49) 
presented preliminary data suggesting that 6 months of 
treatment with the omega-3 fatty acids can reverse the 
abnormal coronary vasoconstriction in response to acetyl- 
choline il patients with early atherosclerosis. 
Figme 4. EUecr of atherosclerosis ,c- 
@essiOn on endorhelium-dependent ws- 
cuki, relaxarion in rraponrr to drombin. 
Reprerentadve aampler of w”sio” re- 
cordbus fmm iliac atteries fmm normal 
monkeys. monkeys fed a high chol~s- 
teml die1 for 18 months fathe,orclc,ow 
and monkeys fed a high cholesterol diet 
for 18 months followed by P “~,,,,a, met 
for 18 months (regrcsrion, ~,e rhown. 
Atherorclcrosis markedly impaired Ihe 
endotheliumdependem wc”la, relax- 
ation in response to thmmbm. After re- 
gnssion of athsroscleroris. ,&xadon I” 
rerfnnre to thmmbm was restored 10 
“Olm8.L FGF,a = Qma,aglandin Fxo. Re. 
printed fmm Harrison et al. (48) with 
pemdsrio” afrhe Am&an Hean Asso- 
ciation, Inc. 
Conclusions 
It is now clear thab endothelium plays an importam role in 
modulating vascular tone both in large vessels and in the 
microcirculation. Furthermore. endothelial cell dysfunclion 
or removal can dramatically alter responses to a variety of 
vasoactive circulating compounds. This has obvious impli- 
cations in the setting of the immediate postangioplasty 
period and may influence the long-term sequelae of angio- 
plasty. The endalbelium also has important antilhrombotic 
properties. These include the elaboration of prostacyclin and 
endothelium.derived relaxing factor. tiwe plasmininogen 
activator and other anrithrombotic substances. Loss or 
dysfunction d the endothelium may result in the deposition 
of platelets, the release of pnfent growth factors and even- 
tually predispose to intimal proliferaion and restenosi%. 
Finally, endothelial dysfunction may predispose to altered 
neurohumoral regulation of coronary vascular tone both 
immediately after and during the first several months after 
angioplasty. 
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